Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism (Journal article)

Liberopoulos, E./ Miltiadous, G./ Elisaf, M. S.

It is well known that thyroid hormones modulate lipoprotein metabolism. Thus, the presence of clinical or subclinical hyperthyroidism may influence lipid parameters of dyslipidaemic patients and the efficacy of hypolipidaemic therapy. Here we present a patient with mixed hyperlipidaemia whose impressive improvement of his lipid profile following ciprofibrate administration pointed towards the diagnosis of asymptomatic underlying subclinical hyperthyroidism.
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Cholesterol, HDL/blood,Cholesterol, LDL/blood,Clofibric Acid/analogs & derivatives/therapeutic use,Fibric Acids,Humans,Hyperlipidemias/complications/*drug therapy,Hyperthyroidism/complications/*diagnosis,Hypolipidemic Agents/*therapeutic use,Lipids/*blood,Male,Middle Aged,Thyrotropin/blood,Thyrotropin-Releasing Hormone/diagnostic use,Thyroxine/blood,Triglycerides/blood,Triiodothyronine/blood
ISSN: 1462-8902
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Liberopoulos-2001-Impressive lipid cha.pdf38.07 kBAdobe PDFView/Open    Request a copy

 Please use this identifier to cite or link to this item:
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.